Top Markets
#1 MowCat MowCat +48.94%
#2 Bermuda Shorts Bermuda Shorts +25.42%
#3 aPriori aPriori +21.46%
#4 Biconomy Biconomy +19.82%
#5 Derive Derive +19.05%
#6 Velvet Velvet +18.18%
#7 Quack AI Quack AI +17.27%
#8 Audiera Audiera +15.85%
#9 Perle Perle +14.87%
#10 Palladium Network Palladium Network +13.69%
Coin of the day
MowCat MowCat
Настройки
Язык
Pусский
Валюта
USD
Тема
Tricida, Inc. Tricida, Inc.

Tricida, Inc.

TCDA
Ранг среди акций #35026
Tricida, Inc. operates as a biopharmaceutical firm with a primary focus on the... Tricida, Inc. operates as a biopharmaceutical firm with a primary focus on the advancement and market introduction of veverimer (TRC101). This compound, an orally ingested, non-systemic polymer, has successfully concluded its Phase III clinical trials. Veverimer is designed to address metabolic acidosis in individuals suffering from chronic kidney disease by specifically targeting and eliminating excess acid within the gastrointestinal tract. The company was established in 2013 and is headquartered in South San Francisco, California.
Цена акции
$0.108
Последняя синхронизация: 2023-01-23
Рыночная капитализация
$4.56M
Изменение (1 день)
-10.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Tricida, Inc. (TCDA)

Категория

Healthcare
История цены акций Tricida, Inc. (TCDA)
Наивысшая цена закрытия: $0.16 2023-01-01

Наименьшая цена закрытия: $27.95 2018-06-01
История цены акций Tricida, Inc. с 2018 по 2026
Годовая динамика цены акций
Год Результативность
2023 -15.79%
2022 -97.77%
2021 12.62%
2020 -81.33%
2019 39.94%
2018 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE